{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:11:28Z","timestamp":1778998288873,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10067-018-4049-7","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T22:42:03Z","timestamp":1521499323000},"page":"2797-2804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Correlation between IL-17A\/F, IL-23, IL-35 and IL-12\/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet\u2019s patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Cemile","family":"Sonmez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul Atak","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turan Hilmi","family":"Yesil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamit","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna","family":"Sezgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridvan","family":"Mercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Eftal","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulderen Yanikkaya","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"issue":"3","key":"4049_CR1","first-page":"371","volume":"5","author":"D Erer","year":"2009","unstructured":"Erer D, Gogus F, Tumer NB, Gunendi Z, Iriz E, Imren VY, Oktar GL (2009) Prevalence of Beh\u00e7et\u2019s syndrome in patients presenting with venous thrombosis: prospective study in a cardiovascular outpatient clinic. Arch Med Sci 5(3):371\u2013375","journal-title":"Arch Med Sci"},{"issue":"1","key":"4049_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","volume":"7","author":"MJ Zeidan","year":"2016","unstructured":"Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P (2016) Behcet\u2019s disease physiopathology: a contemporary review. Auto Immun Highlights 7(1):4","journal-title":"Auto Immun Highlights"},{"key":"4049_CR3","first-page":"86","volume":"28","author":"H Direskeneli","year":"2010","unstructured":"Direskeneli H, Mumcu G (2010) A possible decline in the incidence and severity of Behcet\u2019s disease: implications for an infectious aetiology and oral health. Clin Exp Rheumatol 28:86\u201390","journal-title":"Clin Exp Rheumatol"},{"key":"4049_CR4","doi-asserted-by":"crossref","unstructured":"Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet 42(8):698\u2013702","DOI":"10.1038\/ng.625"},{"issue":"3","key":"4049_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10067-005-0046-8","volume":"25","author":"H Bodur","year":"2006","unstructured":"Bodur H, Borman P, Ozdemir Y, Atan C, Kural G (2006) Quality of life and life satisfaction in patients with Beh\u00e7et\u2019s disease: relationship with disease activity. Clin Rheumatol 25(3):329\u2013333","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4049_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.5603\/FHC.2011.0088","volume":"49","author":"W Kleczynska","year":"2011","unstructured":"Kleczynska W, Jakiela B, Plutecka H, Milewski M, Sanak M, Musial J (2011) Imbalance between Th17 and regulatory T cells in systemic lupus erythematosus. Folia Histochem Cytobiol 49(4):646\u2013653","journal-title":"Folia Histochem Cytobiol"},{"key":"4049_CR7","unstructured":"Mumcu G, Inanc N, Aydin SZ, Ergun T, Direskeneli H (2009) Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 27:32\u201336"},{"key":"4049_CR8","first-page":"32","volume":"31","author":"SY Na","year":"2013","unstructured":"Na SY, Park MJ, Park S, Lee ES (2013) Up regulation of Th17 and related cytokines in Behcet\u2019s disease corresponding to disease activity. Clin Exp Rheumatol 31:32\u201340","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"4049_CR9","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","volume":"60","author":"M Zierhut","year":"2003","unstructured":"Zierhut M, Mizuki N, Ohno S, Inoko H, G\u00fcl A, Onoe K, Isogai E (2003) Human genome and diseases: review. immunology and functional genomics of Beh\u00e7et\u2019s disease. Cell Mol Life Sci 60(9):1903\u20131922","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"4049_CR10","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","volume":"42","author":"MA Frassanito","year":"1999","unstructured":"Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Beh\u00e7et\u2019s disease. Arthritis Rheum 42(9):1967\u20131974","journal-title":"Arthritis Rheum"},{"key":"4049_CR11","first-page":"27","volume":"28","author":"A Ferrante","year":"2010","unstructured":"Ferrante A, Ciccia F, Principato A, Giardina AR, Impastato R, Peralta S, Triolo G (2010) A Th1 but not a Th17 response is present in the gastrointestinal involvement of Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 28:27\u201330","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4049_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1586\/eop.12.30","volume":"7","author":"K Hamzaoui","year":"2012","unstructured":"Hamzaoui K, Hamzaoui A (2012) Immunological responses in patients with Beh\u00e7et\u2019s disease: advances in understanding. Expert Rev Ophthalmol 7(3):261\u2013270","journal-title":"Expert Rev Ophthalmol"},{"issue":"2","key":"4049_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00296-008-0664-y","volume":"29","author":"WC Jang","year":"2008","unstructured":"Jang WC, Nam YH, Ahn YC, Lee SH, Park SH, Choe JY, Lee SS, Kim SK (2008) Interleukin-17F gene polymorphisms in Korean patients with Beh\u00e7et\u2019s disease. Rheumatol Int 29(2):173\u2013178","journal-title":"Rheumatol Int"},{"issue":"4","key":"4049_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K (2002) Cytokine profile in Behcet\u2019s disease patients. Relationship Disease Activity. Scand J Rheumatol 31(4):205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"4049_CR15","doi-asserted-by":"crossref","unstructured":"Alayli G, Ayd\u0131n F, Coban AY, S\u00fcll\u00fc Y, Cant\u00fcrk F, Bek Y, Durupinar B, Cant\u00fcrk T (2007) T helper 1 type cytokines polymorphism: association with susceptibility to Beh\u00e7et\u2019s disease. Clin Rheumatol 26(8):1299\u20131305","DOI":"10.1007\/s10067-006-0503-z"},{"key":"4049_CR16","doi-asserted-by":"crossref","unstructured":"Korn T, Reddy J, Gao W et al (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13(4):423\u2013431","DOI":"10.1038\/nm1564"},{"issue":"4","key":"4049_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.12659\/MSM.881720","volume":"17","author":"K Hamzaoui","year":"2011","unstructured":"Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A (2011) Expression of Th17 and ROR\u03b3T m RNA in Behcet\u2019s disease. Med Sci Monit 17(4):227\u2013234","journal-title":"Med Sci Monit"},{"issue":"1","key":"4049_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2249.2011.04543.x","volume":"168","author":"J Shimizu","year":"2012","unstructured":"Shimizu J, Takai N, Fujiwara N et al. (2012) Excessive CD4+ T cells co-expressing interleukin-17 and interferon-\u03b3 in patients with Beh\u00e7et\u2019s disease. Clin Exp Immunol 168(1):68\u201374","journal-title":"Clin Exp Immunol"},{"key":"4049_CR19","doi-asserted-by":"crossref","unstructured":"Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedqwick JD, Cua DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198(12):1951\u20131957","DOI":"10.1084\/jem.20030896"},{"issue":"7","key":"4049_CR20","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1167\/iovs.07-1390","volume":"49","author":"W Chi","year":"2008","unstructured":"Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A (2008) Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis. Invest Ophthalmol Vis Sci 49(7):3058\u20133064","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4049_CR21","doi-asserted-by":"crossref","unstructured":"Chan JR, Blumenschein W, Murphy E et al (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2 -dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203(12):2577\u20132587","DOI":"10.1084\/jem.20060244"},{"issue":"3","key":"4049_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/icb.2010.137","volume":"89","author":"M Miyara","year":"2011","unstructured":"Miyara M, Sakaguchi S (2011) Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 89(3):346\u2013351","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"4049_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2492\/inflammregen.31.296","volume":"31","author":"J Shimizu","year":"2010","unstructured":"Shimizu J, Yoshikawa H, Takada E, Hirotsu C, Suzuki N (2010) Unbalanced helper T cell function in Behcet\u2019s disease. Inflamm Regen 31(3):296\u2013301","journal-title":"Inflamm Regen"},{"issue":"5","key":"4049_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1172\/JCI200317464","volume":"112","author":"C Becker","year":"2003","unstructured":"Becker C, Wirtz S, Blessing M et al. (2003) Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 112(5):693\u2013706","journal-title":"J Clin Invest"},{"issue":"3","key":"4049_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","volume":"128","author":"G Geri","year":"2011","unstructured":"Geri G, Terrier B, Rosenzwaig M et al. (2011) Critical role of IL-21 in modulating Th17 and regulatory T cells in Beh\u00e7et disease. J Allergy Clin Immunol 128(3):655\u2013664","journal-title":"J Allergy Clin Immunol"},{"key":"4049_CR26","doi-asserted-by":"crossref","unstructured":"Hamzaoi K, Borhani Haghighi A, Ghorbel IB, Houman H (2011) RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Beh\u00e7et\u2019s disease. J Neuroimmunol 233(1\u20132):249\u2013253","DOI":"10.1016\/j.jneuroim.2011.01.012"},{"issue":"5","key":"4049_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"J Zhu","year":"2008","unstructured":"Zhu J, Paul WE (2008) CD4 cells: fates, functions and faults. Blood 112(5):1557\u20131569","journal-title":"Blood"},{"key":"4049_CR28","doi-asserted-by":"publisher","unstructured":"Peizeng Y, Wang C, Hou S, Lei B, Kijlstra A, Li DQ (2014) Advances in pathogenesis of Behcet\u2019s disease and Vogt-Koyanagi-Harada syndrome. https:\/\/doi.org\/10.5772\/57586","DOI":"10.5772\/57586"},{"issue":"7559","key":"4049_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani N, Vesely MC, Iseppon A et al. (2015) Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523(7559):221\u2013225","journal-title":"Nature"},{"issue":"2","key":"4049_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.imlet.2015.08.001","volume":"167","author":"E Bouali","year":"2015","unstructured":"Bouali E, Kaabachi W, Hamzaoui A, Hamzaoui K (2015) Interleukin-37 expression is decreased in Beh\u00e7et\u2019s disease and is associated with inflammation. Immunol Lett 167(2):87\u201394","journal-title":"Immunol Lett"},{"issue":"4","key":"4049_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2174\/1566524014666140414210831","volume":"14","author":"Z Ye","year":"2014","unstructured":"Ye Z, Wang C, Kijlstra A, Zhou X, Yang P (2014) A possible role for interleukin 37 in the pathogenesis of Behcet\u2019s disease. Curr Mol Med 14(4):535\u2013542","journal-title":"Curr Mol Med"},{"issue":"2","key":"4049_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","volume":"157","author":"A Nalbandian","year":"2009","unstructured":"Nalbandian A, Crispin JC, Tsokos GC (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157(2):209\u2013215","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"4049_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/ni.1741","volume":"10","author":"A Doreau","year":"2009","unstructured":"Doreau A, Belot A, Bastid J et al. (2009) Interleukin 17 acts in synergy with B-cell activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10(7):778\u2013785","journal-title":"Nat Immunol"},{"issue":"5","key":"4049_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24499","volume":"60","author":"J Yang","year":"2009","unstructured":"Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X, Wan L, Li M (2009) Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60(5):1472\u20131483","journal-title":"Arthritis Rheum"},{"key":"4049_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.imlet.2017.08.008","volume":"190","author":"W Kaabachi","year":"2017","unstructured":"Kaabachi W, Bouali E, Berra\u00efes A, Dhifallh IB, Hamdi B, Hamzaoui K, Hamzaoui A (2017) Interleukin-26 is overexpressed in Beh\u00e7et\u2019s disease and enhances Th17 related-cytokines. Immunol Lett 190:177\u2013184","journal-title":"Immunol Lett"},{"issue":"2","key":"4049_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/ar2964","volume":"12","author":"K Shah","year":"2010","unstructured":"Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Kang I (2010) Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 12(2):53. https:\/\/doi.org\/10.1186\/ar2964","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"4049_CR37","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00296-010-1771-0","volume":"32","author":"Q Xing","year":"2012","unstructured":"Xing Q, Wang B, Su H, Cui J, Li J (2012) Elevated Th17 cells are accompanied by Foxp3+ Treg cells decrease in paients with lupus nephritis. Rheumatol Int 32(4):949\u2013958","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4049-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4049-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4049-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T00:20:50Z","timestamp":1570926050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4049-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4049"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4049-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}